Literature DB >> 6715505

Plasma cholesterol and cancer morbidity and mortality in an adult community.

D L Wingard, M H Criqui, M J Holdbook, E Barrett-Connor.   

Abstract

The relationship between plasma cholesterol and seven-year cancer morbidity and mortality was assessed in 4035 residents of Rancho Bernardo , CA, aged 40-89 years. Cancer was the underlying cause of death for 139 persons and occurred in an additional 168 individuals after the 1972-74 cholesterol measurement. The age-adjusted cancer mortality rate per years of experience showed a slightly U-shaped relationship with cholesterol levels in men. For women, little association was seen between cancer mortality and cholesterol levels. Age-adjusted cancer morbidity rates per years of experience, indicated no association for men or women. Mean cholesterol levels did not differ significantly by cancer site. In addition, analysis of cholesterol levels by length of time between cholesterol measurement and cancer occurrence showed no significant trends, suggesting the progression of subclinical cancer did not result in lower cholesterol levels. In summary, in this population no significant association of cholesterol and cancer was seen in men or women.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6715505     DOI: 10.1016/0021-9681(84)90107-3

Source DB:  PubMed          Journal:  J Chronic Dis        ISSN: 0021-9681


  6 in total

Review 1.  Plasma cholesterol, lipid lowering, and risk for cancer. An update of the results from epidemiologic studies and intervention trials.

Authors:  K J Lackner; G Schettler; W Kübler
Journal:  Klin Wochenschr       Date:  1989-09-15

Review 2.  The complex interplay between cholesterol and prostate malignancy.

Authors:  Keith R Solomon; Michael R Freeman
Journal:  Urol Clin North Am       Date:  2011-06-22       Impact factor: 2.241

3.  Time-dependent association of total serum cholesterol and cancer incidence in a cohort of 172,210 men and women: a prospective 19-year follow-up study.

Authors:  A M Strasak; R M Pfeiffer; L J Brant; K Rapp; W Hilbe; W Oberaigner; S Lang; W Borena; H Concin; G Diem; E Ruttmann; B Glodny; K P Pfeiffer; H Ulmer
Journal:  Ann Oncol       Date:  2009-01-22       Impact factor: 32.976

4.  Low serum cholesterol and the risk of cancer: an analysis of the published prospective studies.

Authors:  M R Law; S G Thompson
Journal:  Cancer Causes Control       Date:  1991-07       Impact factor: 2.506

5.  Serum cholesterol and subsequent risk of cancer: results from the BUPA study.

Authors:  N J Wald; S G Thompson; M R Law; J W Densem; A Bailey
Journal:  Br J Cancer       Date:  1989-06       Impact factor: 7.640

6.  Total serum cholesterol and cancer incidence in the Metabolic syndrome and Cancer Project (Me-Can).

Authors:  Susanne Strohmaier; Michael Edlinger; Jonas Manjer; Tanja Stocks; Tone Bjørge; Wegene Borena; Christel Häggström; Anders Engeland; Gabriele Nagel; Martin Almquist; Randi Selmer; Steinar Tretli; Hans Concin; Göran Hallmans; Håkan Jonsson; Pär Stattin; Hanno Ulmer
Journal:  PLoS One       Date:  2013-01-23       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.